Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at NDORMS have made an important advancement in the field of single-cell transcriptomics by developing a novel bead design that reduces errors in DNA synthesis and improves the reliability of gene expression measurements.

DNA strand

Single-cell transcriptomics has revolutionised the study of cellular diversity and function by enabling gene expression analysis at single-cell resolution. The technique is crucial for understanding how different cells function, how they communicate, and how they contribute to various biological processes and diseases.

However, technical errors in the synthesis of oligonucleotides (short DNA sequences)—particularly in droplet-based methods such as Drop-seq and 10x Chromium—frequently lead to inaccurate results, causing researchers to discard valuable data. These synthesis errors obscure identification of the cell barcode (which identifies the cell) and UMI (unique molecular identifier) resulting in substantial data loss and limiting sequencing efficiency.

Published in Communications Biology, Associate Professor Adam Cribbs and Dr. Jianfeng Sun at the Botnar Institute for Musculoskeletal Sciences identified a major source of error: premature truncation of UMIs before sequencing.  To address this, they developed a novel bead design that improves the reliability of gene expression measurements by mitigating truncation errors in UMIs prior to sequencing.

They added what they call an “anchor” between two important parts of the sequence: between the barcode and UMI. This anchor provides a clear demarcation point, enhancing UMI recognition and minimising synthesis errors.

The work builds on the Oxford team’s previous homotrimer UMI error correction strategy, which focused on errors arising after sequencing. In contrast, the new anchor-interposed approach tackles UMI errors at the pre-sequencing stage, further advancing long-read transcriptomics. 

 

Schematic view of two bead design schemes to address errors arising before and after sequencing, respectively Schematic view of two bead design schemes to address errors arising before and after sequencing, respectively

 

Key findings:

  • Improved UMI accuracy: The new bead design enhances UMI identification, improving molecular quantification. UMIs are critical for counting the number of unique RNA molecules captured from each cell.
  • Increased transcript detection: The researchers observed a marked increase in the number of detected transcripts per cell, enhancing the reliability of single-cell sequencing.
  • Minimal impact on synthesis cost: The approach effectively counteracts synthesis limitations, such as oligonucleotide purification challenges, with only a small additional nucleotide sequence required.

Dr. Jianfeng Sun, first author of the study, explained: ‘By incorporating a four-base anchor sequence into droplet-based beads, we have improved barcode and UMI recognition, leading to a greater number of high-quality long reads. This new bead design enhances the overall reliability of single-cell sequencing.’

Beyond its direct impact on sequencing accuracy, the study has broad implications for single-cell biology. Advancing the technical capabilities of single-cell sequencing is crucial for accelerating biological discovery and understanding complex cellular systems to advance science and improve healthcare outcomes.

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8th October 2026.

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

NIHR fellowship to support national trial evaluating rehabilitation after kneecap dislocation

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Professor Afsie Sabokbar retires after more than 30 years at NDORMS

Botnar Institute Director of Graduate Studies, Professor Afsie Sabokbar, is retiring after more than 30 years at NDORMS.

Researchers funded to cure – rather than manage – inflammatory disease

Researchers from the Kennedy Institute of Rheumatology will join international partners in a bid to transform how chronic inflammatory disease is treated.